JOINED THE SCIENTIFIC COUNCIL IN 2000
Global Therapeutic Head, Neuroscience
Johnson and Johnson (J&J) Pharmaceutical Research and
Adjunct Professor in Psychiatry and Behavioral Sciences
Duke University School of Medicine
Dr. Manji leads a preclinical and clinical global team whose broad goal is to discover and develop new therapeutics for major neurologic, psychiatric and pain-related diseases with a high unmet need for effective treatments. Dr. Manji’s research has helped to conceptualize severe neuropsychiatric disorders as genetically influenced disorders of synaptic and neural plasticity, and led to the investigation of key novel therapeutics. The major focus of his research has been the investigation of disease-and treatment-induced changes in gene and protein networks that regulate synaptic and neural plasticity in brain and behavior disorders.
Before joining J&J, Dr. Manji was Chief of the Laboratory of Molecular Pathophysiology and Experimental Therapeutics at the NIMH, the largest program of its kind in the world.
NARSAD Grants: Independent Investigator 1998
Foundation Prizes: 1999 Falcone Prize for Outstanding Achievement in Affective Disorders Research (renamed the Colvin Prize in 2012)